Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma

American Journal of Gastroenterology

Volumn 108, Issue 7, 2013, Pages 1082-1093

  Rajendra, Shanmugarajah ^a,b,c   Wang, Bin ^a,b   Snow, Elizabeth T ^d   Sharma, Prateek ^e   Pavey, Darren ^a,b,c   Merrett, Neil ^c,f   Ball, Madeleine J ^d   Brain, Terry ^g   Fernando, Ruchira ^g   Robertson, Iain K ^d  

^a INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

^g LAUNCESTON GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INCIDENCE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; WART VIRUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CELL TRANSFORMATION, VIRAL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P16; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEIN P14ARF; YOUNG ADULT;

EID: 84880219980     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.94     Document Type: Article

References (53)

1. Wang KK , Sampliner RE. Updated guidelines 2008 fo. The diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008 ; 103 : 788-97.
2. Pohl H , Welch HG. The role of overdiagnosis and reclassifi cation i. The marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005 ; 97 : 142-6.
3. Rajendra S , Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Th erap Adv Gastroenterol 2012 ; 5 : 285-99.
4. Rajendra S , Robertson IK. Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: is HP. The common denominator? J Clin Pathol 2010 ; 63 : 1-3.
5. Rajendra S , Robertson IK. Barrett's oesophagus; acid an. The human papilloma virus? J Clin Virol 2009 ; 44 : 176.
6. Chang F , Syrjanen S , Shen Q et al. Human papillomavirus involvement in esophageal carcinogenesis i. The high-incidence area of China. A study of 700 cases by screening and type-specifi c in situ hybridization. Scand J Gastroenterol 2000 ; 35 : 123-30.
7. Farhadi M , Tahmasebi Z , Merat S et al. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005 ; 11 : 1200-3.
8. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002 ; 55 : 721-8.
9. D' Souza G , Kreimer AR , Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007 ; 356 : 1944-56.
10. Chaturvedi AK , Engels EA , Pfeiff er RM et al. Human papillomavirus and rising oropharyngeal cancer incidence i. The United States. J Clin Oncol 2011 ; 29 : 4294-301.
11. Nasman A , Attner P , Hammarstedt L et al. Incidence of human papillomavirus (HPV) positivetonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009 ; 125 : 362-6.
12. Hocking JS , Stein A , Conway EL et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPVassociated oropharyngeal cancers. Br J Cancer 2011 ; 104 : 886-91.
13. Rai N , Jenkins GJ , McAdam E et al. Human papillomavirus infection in Barrett's oesophagus i. The UK: an infrequent event. J Clin Virol 2008 ; 43 : 250-2.
14. El-Serag HB , Hollier JM , Gravitt P et al. Human papillomavirus an. The risk of Barrett's esophagus. Dis Esophagus 2012 ; DOI:10.1111/j.1442- 2050.2012.01392.x.
15. Iyer A , Rajendran V , Adamson CS et al. Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic signifi cance. J Clin Virol 2011 ; 50 : 205-8.
16. Acevedo-Nuno E , Gonzalez-Ojeda A , Vazquez-Camacho G et al. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Res 2004 ; 24 : 1319-23.
17. Xia HH , Kalantar JS , Mitchell HM et al. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Th er 2000 ; 14 : 615-24.
18. Rajendra S , Ackroyd R , Robertson IK et al. Helicobacter pylori, ethnicity, an. The gastroesophageal refl ux disease spectrum: a study fro. The East. Helicobacter 2007 ; 12 : 177-83.
19. Tornesello ML , Monaco R , Nappi O et al. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma o. The oesophagus. J Clin Virol 2009 ; 45 : 28-33.
20. Sotlar K , Stubner A , Diemer D et al. Detection of high-risk human papillomavirus E6 and E7 oncogenetranscripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 2004 ; 74 : 107-16.
21. Hsu EM , McNicol PJ , Guijon FB et al. Quantifi cation of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reversetranscriptase polymerase chain reaction. Int J Cancer 1993 ; 55 : 397-401.
22. Selinka HC , Sotlar K , Klingel K et al. Detection of human papillomavirus 16 transcriptional activity in cervical intraepithelial neoplasia grade III lesions and cervical carcinomas by nested reversetranscription- polymerase chain reaction and in situ hybridization. Lab Invest 1998 ; 78 : 9-18.
23. Kong CS , Balzer BL , Troxell ML et al. p16INK4A immunohistochemistry is superior to HPV in situ hybridization fo. The detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007 ; 31 : 33-43.
24. Keating JT , Cviko A , Riethdorf S et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001 ; 25 : 884-91.
25. Sano T , Oyama T , Kashiwabara K et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998 ; 153 : 1741-8.
26. Parkin DM , Bray F. Chapter 2: Th e burden of HPV-related cancers. Vaccine 2006 ; 24 (Suppl 3) S3/11-25.
27. Schiff man M , Castle PE , Jeronimo J et al. Human papillomavirus and cervical cancer. Lancet 2007 ; 370 : 890-907.
28. Howley PM , Lowy DR. Papillomaviruses. In: Knipe DM, Howley PM (eds). Fields Virology, 5 thedn, Vol. 2. Lippincott Williams and Wilkins: Philadelphia, 2007 , pp2299 - 354.
29. Baldwin A , M unger K. Molecular events associated with human papillomavirus-induced human cancers. In: Khalili K, Jeang KT (eds). Viral Oncology: basic science and clinical applications. John Wiley & Sons, Inc: Hoboken, 2010 , pp23 - 55.
30. Ng WK , Cheung LK , Li AS et al. Transitional cell metaplasia o. The uterine cervix is related to human papillomavirus: molecular analysis in seven patients with cytohistologic correlation. Cancer 2002 ; 96 : 250-8.
31. Herfs M , Yamamoto Y , Laury A et al. A discrete population of squamocolumnar junction cells implicated i. The pathogenesis of cervical cancer. Proc Natl Acad Sci USA 2012 ; 109 : 10516-21.
32. Wang X , Ouyang H , Yamamoto Y et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011 ; 145 : 1023-35.
33. Nicholson AM , Graham TA , Simpson A et al. Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor. Gut 2012 ; 61 : 1380-9.
34. Quante M , Bhagat G , Abrams JA et al. Bile acid and infl ammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012 ; 21 : 36-51.
35. de Sanjose S , Diaz M , Castellsague X et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007 ; 7 : 453-9.
36. Garland SM , Brotherton JM , Condon JR et al. Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med 2011 ; 9 : 104.
37. Tabrizi SN , Brotherton JM , Kaldor JM et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012 ; 206 : 1645-51.
38. Zhang D , Zhang Q , Zhou Let al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010 ; 10 : 650.
39. Gillison ML , Broutian T , Pickard RK et al. Prevalence of oral HPV infection i. The United States, 2009 - 2010. JAMA 2012 ; 307 : 693-703.
40. Sedlak-Weinstein L , Remmerbach TW. Prevalence of HPV in suspicious oral lesions. In: The 47 th Annual Scientifi c Meeting o. The Australia and New Zealand Division o. The International Association of Dental Research; 2007 September 23-26; Adelaide, South Australia.
41. Lawton G , Th omas S , Schonrock J et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 1992 ; 21 : 265-9.
42. Mehanna H , Jones TM , Gregoire V et al. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010 ; 340 : c1439.
43. Chung CH , Raben D. p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer. J Clin Oncol 2010 ; 28 : 4103-4.
44. Marur S , D ' Souza G , Westra WH et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010 ; 11 : 781-9.
45. Psyrri A , Gouveris P , Vermorken JB. Human papillomavirus-related head and neck tumors: clinical and research implication. Curr Opin Oncol 2009 ; 21 : 201-5.
46. Ang KK , Harris J , Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010 ; 363 : 24-35.
47. Shi W , Kato H , Perez-Ordonez B et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009 ; 27 : 6213-21.
48. Mulvany NJ , Allen DG , Wilson SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008 ; 40 : 335-44.
49. Bhat S , Coleman HG , Yousef F et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011 ; 103 : 1049-57.
50. Hvid-Jensen F , Pedersen L , Drewes AM et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011 ; 365 : 1375-83.
51. Rajendra S , Sharma P. Barrett's esophagus and cancer risk: a more realistic estimate. Semin Th orac Cardiovasc Surg 2011 ; 23 : 261-2.
52. Trope A , Sjoborg K , Eskild A et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009 ; 47 : 2458-64.
53. Benevolo M , Vocaturo A , Caraceni D et al. Sensitivity, specifi city, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triagetest for cervical cytology and HPV DNA test. J Clin Microbiol 2011 ; 49 : 2643-50